IDEA project_​

IDEA is gover­ned by an Inde­pen­dent Super­vi­sory Group of aca­de­mic toxi­co­lo­gists who set the agen­da, review pro­gress and publish annual reports.
Through open, mul­ti-sta­kehol­der workshops, the pro­ject builds con­sen­sus on three pillars:

Hazard cha­rac­te­ri­sa­tion – crea­tion of the Refe­ren­ce Che­mi­cal Potency List, giving agreed potency bands for 106 esta­blished fra­gran­ce allergens.

Expo­su­re assess­ment – deve­lop­ment of the refi­ned Quan­ti­ta­ti­ve Risk Assess­ment (QRA2) model that com­bi­nes con­su­mer habits data with pro­duct-spe­ci­fic der­mal exposure.

Vali­da­tion & moni­to­ring – Euro­pe-wide cli­ni­cal sur­vei­llan­ce stu­dies that track real-world trends in con­tact allergy and feed tho­se fin­dings back into safety limits.

Out­puts are published free of char­ge, allo­wing autho­ri­ties and com­pa­nies to apply a com­mon scien­ti­fic yards­tick when for­mu­la­ting, regu­la­ting or refor­mu­la­ting fra­gran­ced goods